UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group

Cancer reports, 2024-02, Vol.7 (2), p.e1931-n/a

2024

Volltextzugriff (PDF)

Favorable outcome of PML‐RARα short isoform and FLT3‐ITD mutation in a patient with several adverse prognostic markers: A case report

Clinical case reports, 2023-07, Vol.11 (7), p.e07637-n/a

2023

Volltextzugriff (PDF)

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Blood, 2012-04, Vol.119 (17), p.3917-3924

2012

Volltextzugriff (PDF)

Advances in stem cell mobilization

Blood reviews, 2012-11, Vol.26 (6), p.267-278

2012

Volltextzugriff (PDF)

Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East

Bone marrow transplantation (Basingstoke), 2021-09, Vol.56 (9), p.2144-2151

2021

Volltextzugriff (PDF)

Durable remission of a patient with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma

Hematology/oncology and stem cell therapy, 2021-03, Vol.14 (1), p.71-75

2021

Volltextzugriff (PDF)

Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21 (10), p.720-723

2021

Volltextzugriff (PDF)

Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?

Hematology/oncology and stem cell therapy, 2020-09

2020

Volltextzugriff (PDF)

Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis

The American journal of case reports, 2020-09, Vol.21, p.e922971-e922971-9

2020

Volltextzugriff (PDF)

CD56 and RUNX1 isoforms in AML prognosis and their therapeutic potential

Hematology/oncology and stem cell therapy, 2016-09, Vol.9 (3), p.129-130

2016

Volltextzugriff (PDF)

Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia

Pakistan journal of medical sciences, 2016-12, Vol.32 (6), p.1494-1499

2016

Volltextzugriff (PDF)

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant

Biology of blood and marrow transplantation, 2016-07, Vol.22 (7), p.1324-1329

2016

Volltextzugriff (PDF)

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Blood, 2021-11, Vol.138 (Supplement 1), p.4558-4558

2021

Volltextzugriff (PDF)

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Blood, 2021-11, Vol.138 (Supplement 1), p.4532-4532

2021

Volltextzugriff (PDF)

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Blood, 2021-11, Vol.138 (Supplement 1), p.4423-4423

2021

Volltextzugriff (PDF)

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Blood, 2021-11, Vol.138 (Supplement 1), p.4258-4258

2021

Volltextzugriff (PDF)

Very High Seroprevalence of CMV and EBV Among a Large Series of Patients with Hematological Malignancies at a Tertiary Care Center in Saudi Arabia - a Case for Investigating Cooperativity of Viruses in Carcinogenesis?

Blood, 2019-11, Vol.134 (Supplement_1), p.5818-5818

2019

Volltextzugriff (PDF)

Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and G-CSF Combination for Patients with Relapsed or Refractory AML

Blood, 2018-11, Vol.132 (Supplement 1), p.5181-5181

2018

Volltextzugriff (PDF)

Blinatumomab With Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S163-S163

2024

Volltextzugriff (PDF)

ALL-676 Blinatumomab With Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S280-S280

2024

Volltextzugriff (PDF)

Role of Serial Positron Emission Tomography (PET) Scans in Indolent Lymphomas' Management - Interim Results from an Ongoing Prospective Study at King Fahd Medical City, Riyadh, Saudi Arabia

Blood, 2018-11, Vol.132 (Supplement 1), p.5342-5342

2018

Volltextzugriff (PDF)

Bortezomib Can Overcome Stroma-Mediated Chemotherapy Resistance in Acute Lymphoblastic Leukemia

Blood, 2012-11, Vol.120 (21), p.2475-2475

2012

Volltextzugriff (PDF)

Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in Four Patients with Hematological Malignancies Treated at King Fahad Medical City, Riyadh, Saudi Arabia

Blood, 2016-12, Vol.128 (22), p.4903-4903

2016

Volltextzugriff (PDF)

Primary Central Nervous System Lymphoma Treatment Outcomes-a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Blood, 2016-12, Vol.128 (22), p.5416-5416

2016

Volltextzugriff (PDF)

Secondary Central Nervous System Involvement with Concurrent Diffuse Large B Cell Lymphoma at Initial Presentation or at Relapse Is Associated with Zero Survival- a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Blood, 2016-12, Vol.128 (22), p.5417-5417

2016

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(36)
Berichte
(2)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Hematology
(6)
Adolescent
(4)
Adult
(4)
Female
(4)
Male
(4)
Middle Aged
(4)
Oncology
(4)
Stem Cell Transplantation
(4)
Aged
(3)
Chemotherapy
(3)
Hematology, Oncology And Palliative Medicine
(3)
Patients
(3)
Young Adult
(3)
Aml
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Biological And Medical Sciences
(2)
Care And Treatment
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group

Favorable outcome of PML‐RARα short isoform and FLT3‐ITD mutation in a patient with several adverse prognostic markers: A case report

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Advances in stem cell mobilization

Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East

Durable remission of a patient with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma

Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?

Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis

CD56 and RUNX1 isoforms in AML prognosis and their therapeutic potential

Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Very High Seroprevalence of CMV and EBV Among a Large Series of Patients with Hematological Malignancies at a Tertiary Care Center in Saudi Arabia - a Case for Investigating Cooperativity of Viruses in Carcinogenesis?

Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and G-CSF Combination for Patients with Relapsed or Refractory AML

Blinatumomab With Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

ALL-676 Blinatumomab With Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Role of Serial Positron Emission Tomography (PET) Scans in Indolent Lymphomas' Management - Interim Results from an Ongoing Prospective Study at King Fahd Medical City, Riyadh, Saudi Arabia

Bortezomib Can Overcome Stroma-Mediated Chemotherapy Resistance in Acute Lymphoblastic Leukemia

Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in Four Patients with Hematological Malignancies Treated at King Fahad Medical City, Riyadh, Saudi Arabia

Primary Central Nervous System Lymphoma Treatment Outcomes-a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Secondary Central Nervous System Involvement with Concurrent Diffuse Large B Cell Lymphoma at Initial Presentation or at Relapse Is Associated with Zero Survival- a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia

Suchergebnisse filtern